Artivion (AORT) Competitors $31.93 +1.08 (+3.50%) As of 01:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AORT vs. NARI, IRTC, TMDX, BLCO, SLNO, INSP, PRCT, NVST, LIVN, and WRBYShould you be buying Artivion stock or one of its competitors? The main competitors of Artivion include Inari Medical (NARI), iRhythm Technologies (IRTC), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Envista (NVST), LivaNova (LIVN), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. Artivion vs. Its Competitors Inari Medical iRhythm Technologies TransMedics Group Bausch + Lomb Soleno Therapeutics Inspire Medical Systems PROCEPT BioRobotics Envista LivaNova Warby Parker Artivion (NYSE:AORT) and Inari Medical (NASDAQ:NARI) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership and media sentiment. Is AORT or NARI more profitable? Artivion has a net margin of -5.49% compared to Inari Medical's net margin of -13.68%. Artivion's return on equity of 3.63% beat Inari Medical's return on equity.Company Net Margins Return on Equity Return on Assets Artivion-5.49% 3.63% 1.34% Inari Medical -13.68%-10.09%-6.60% Which has better valuation & earnings, AORT or NARI? Inari Medical has higher revenue and earnings than Artivion. Artivion is trading at a lower price-to-earnings ratio than Inari Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArtivion$388.54M3.51-$13.36M-$0.50-63.86Inari Medical$493.63M9.48-$1.64M-$1.35-59.24 Which has more risk and volatility, AORT or NARI? Artivion has a beta of 1.62, indicating that its share price is 62% more volatile than the S&P 500. Comparatively, Inari Medical has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500. Does the media prefer AORT or NARI? In the previous week, Artivion had 3 more articles in the media than Inari Medical. MarketBeat recorded 3 mentions for Artivion and 0 mentions for Inari Medical. Artivion's average media sentiment score of 1.08 beat Inari Medical's score of 0.45 indicating that Artivion is being referred to more favorably in the media. Company Overall Sentiment Artivion Positive Inari Medical Neutral Do institutionals and insiders believe in AORT or NARI? 86.4% of Artivion shares are owned by institutional investors. Comparatively, 91.0% of Inari Medical shares are owned by institutional investors. 7.6% of Artivion shares are owned by insiders. Comparatively, 10.6% of Inari Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Do analysts prefer AORT or NARI? Artivion presently has a consensus target price of $32.40, indicating a potential upside of 1.47%. Inari Medical has a consensus target price of $69.22, indicating a potential downside of 13.44%. Given Artivion's stronger consensus rating and higher possible upside, equities analysts plainly believe Artivion is more favorable than Inari Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Artivion 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17Inari Medical 0 Sell rating(s) 12 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14 SummaryArtivion beats Inari Medical on 11 of the 17 factors compared between the two stocks. Get Artivion News Delivered to You Automatically Sign up to receive the latest news and ratings for AORT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AORT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AORT vs. The Competition Export to ExcelMetricArtivionMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$1.36B$6.87B$5.50B$20.64BDividend YieldN/A1.16%5.39%3.77%P/E Ratio-63.8626.6027.4228.03Price / Sales3.51100.84398.5038.91Price / Cash36.8621.0136.1321.91Price / Book4.854.758.014.60Net Income-$13.36M$173.18M$3.16B$984.95M7 Day Performance4.42%1.73%2.08%2.95%1 Month Performance12.09%0.37%4.38%5.53%1 Year Performance23.52%28.62%35.81%14.66% Artivion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AORTArtivion2.4695 of 5 stars$31.93+3.5%$32.40+1.5%+20.6%$1.36B$388.54M-63.861,600Positive NewsNARIInari Medical0.4681 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800IRTCiRhythm Technologies1.1904 of 5 stars$150.95+3.6%$138.60-8.2%+44.8%$4.65B$591.84M-48.072,000Positive NewsInsider TradeTMDXTransMedics Group1.6056 of 5 stars$127.53+3.2%$127.33-0.2%-14.3%$4.18B$441.54M93.77210Positive NewsBLCOBausch + Lomb3.3757 of 5 stars$12.01+2.3%$15.54+29.5%-6.2%$4.15B$4.79B24.4413,500SLNOSoleno Therapeutics4.2152 of 5 stars$81.42+1.8%$107.10+31.5%+117.0%$4.03BN/A-17.6230INSPInspire Medical Systems4.8493 of 5 stars$129.88-0.8%$211.91+63.2%-2.7%$3.86B$802.80M59.851,246Positive NewsPRCTPROCEPT BioRobotics2.2141 of 5 stars$58.74-2.5%$90.00+53.2%-7.9%$3.33B$224.50M-34.55430News CoverageNVSTEnvista3.6032 of 5 stars$18.90+0.1%$20.23+7.0%+23.5%$3.20B$2.51B26.6112,300LIVNLivaNova2.9286 of 5 stars$45.57+0.1%$59.29+30.1%-12.9%$2.48B$1.25B-11.142,900WRBYWarby Parker2.1251 of 5 stars$22.02+1.3%$22.88+3.9%+37.0%$2.27B$771.32M-183.503,780 Related Companies and Tools Related Companies Inari Medical Competitors iRhythm Technologies Competitors TransMedics Group Competitors Bausch + Lomb Competitors Soleno Therapeutics Competitors Inspire Medical Systems Competitors PROCEPT BioRobotics Competitors Envista Competitors LivaNova Competitors Warby Parker Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AORT) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artivion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artivion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
